Market Recap: Royalty Pharma plc (RPRX)’s Negative Momentum, Closing at 25.63

The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The closing price of Royalty Pharma plc (NASDAQ: RPRX) was $25.63 for the day, down -0.31% from the previous closing price of $25.71. In other words, the price has decreased by -$0.31 from its previous closing price. On the day, 1.85 million shares were traded. RPRX stock price reached its highest trading level at $25.68 during the session, while it also had its lowest trading level at $25.205.

Ratios:

Our analysis of RPRX’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 13.29 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 4.40. For the most recent quarter (mrq), Quick Ratio is recorded 12.52 and its Current Ratio is at 12.52. In the meantime, Its Debt-to-Equity ratio is 0.94 whereas as Long-Term Debt/Eq ratio is at 0.94.

On May 13, 2022, Scotiabank started tracking the stock assigning a Sector Outperform rating and target price of $53.Scotiabank initiated its Sector Outperform rating on May 13, 2022, with a $53 target price.

Insider Transactions:

Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jan 04 ’24 when RIGGS RORY B sold 35,702 shares for $27.55 per share. The transaction valued at 983,504 led to the insider holds 20,099 shares of the business.

RIGGS RORY B sold 199,098 shares of RPRX for $5,532,276 on Jan 03 ’24. The Director now owns 55,801 shares after completing the transaction at $27.79 per share. On Jan 02 ’24, another insider, RIGGS RORY B, who serves as the Director of the company, sold 235,200 shares for $28.52 each. As a result, the insider received 6,707,081 and left with 254,899 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RPRX now has a Market Capitalization of 15312309248 and an Enterprise Value of 20189984768. As of this moment, Royalty’s Price-to-Earnings (P/E) ratio for their current fiscal year is 14.39, and their Forward P/E ratio for the next fiscal year is 5.85. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 4.50. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.18 while its Price-to-Book (P/B) ratio in mrq is 1.78. Its current Enterprise Value per Revenue stands at 9.019.

Stock Price History:

Over the past 52 weeks, RPRX has reached a high of $31.66, while it has fallen to a 52-week low of $25.43. The 50-Day Moving Average of the stock is -5.84%, while the 200-Day Moving Average is calculated to be -8.78%.

Shares Statistics:

RPRX traded an average of 2.77M shares per day over the past three months and 2815000 shares per day over the past ten days. A total of 446.69M shares are outstanding, with a floating share count of 384.11M. Insiders hold about 15.04% of the company’s shares, while institutions hold 68.88% stake in the company. Shares short for RPRX as of 1718323200 were 15539968 with a Short Ratio of 5.61, compared to 1715731200 on 13280872. Therefore, it implies a Short% of Shares Outstanding of 15539968 and a Short% of Float of 3.5700000000000003.

Dividends & Splits

With its trailing 12-month dividend rate of 0.81, RPRX has a forward annual dividend rate of 0.82. Against a Trailing Annual Dividend Yield of 0.031505253

Most Popular